Author

C. Arrigoni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Marchetto· 2 shared F. Cidre-Aranaz· 2 shared J. Li· 2 shared J. Musa· 2 shared L. Romero-Perez· 2 shared M. F. Orth· 2 shared M. Lolicato· 2 shared M. M. L. Knott· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Marchetto

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

VDAC1 selective molecules promote patients-derived cancer organoids death through mitochondrial-dependent metabolic interference

S. Conti Nibali, S. De Siervi, A. Magri, L. Brocca, S. Mantovani, B. Oliviero, M. U. Mondelli, V. De Pinto, C. Turato, C. Arrigoni, M. Lolicato

This paper identifies VA molecules that selectively target VDAC1 in cancer cells, causing mitochondrial distress and reduced viability, with less impact on healthy cells.

bioRxiv · Dec 4, 2023 · PreprintBiophysics

Quaternary structure independent folding of voltage-gated ion channel pore domain subunits

C. Arrigoni, M. Lolicato, D. Shaya, A. Rohaim, F. Findeisen, C. M. Colleran, P. Dominik, S. S. Kim, J. Schuermann, A. A. Kossiakoff, D. L. Minor

This paper shows that voltage-gated ion channel pore domains can maintain their structure without relying on quaternary interactions, revealing new insights into their folding and assembly.

bioRxiv · Aug 15, 2021Biophysics

Systems biology analysis identifies TCF7L1 as a key regulator of metastasis in Ewing sarcoma

F. Cidre-Aranaz, J. Li, T. L. B. Hoelting, M. F. Orth, R. Imle, S. Kutschmann, G. Ammirati, K. Ceranski, M. J. Carreno-Gonzalez, M. Kasan, A. Marchetto, C. M. Funk, F. Bestvater, S. Bersini, C. Arrigoni, , T. G. P. Gruenewald

bioRxiv · Feb 25, 2021 · PreprintCancer Biology

Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma

A. Marchetto, S. Ohmura, M. F. Orth, J. Li, F. S. Wehweck, M. M. L. Knott, S. Stein, D. Saucier, C. Arrigoni, J. S. Gerke, M. C. Baldauf, J. Musa, M. Dallmayer, T. L. B. Hoelting, M. Moretti, , T. G. P. Grunewald

The paper identifies SOX6 as a therapeutic target in Ewing sarcoma by showing its role in elevating ROS levels, making the disease vulnerable to ROS-inducing drugs.

bioRxiv · Mar 14, 2019Cancer Biology